AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7516831 — intervention group
Group type: EXPERIMENTAL
Intervention: DRE in addition to PSA
Number of subjects: 7350
Study 7516831 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PSA alone for follow-ups every second year
Number of subjects: 7350
Study 7516831 — intervention group
Group type: EXPERIMENTAL
Intervention: Current detection strategy
Number of subjects: 7350
Study 3222164 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem-cilastatin
Number of subjects: 20
Study 3222164 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin plus gentamicin
Number of subjects: 20
Study 30051954 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone mineral (DBBM)
Number of subjects: 100
Study 30051954 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized porcine bone mineral (DPBM)
Number of subjects: 100
Study 28851406 — intervention group
Group type: EXPERIMENTAL
Intervention: Inlife social support intervention
Number of subjects: 122
Study 28851406 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 122
Study 25287137 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness stress management program (8 weeks)
Number of subjects: 38
Study 25287137 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study 24473957 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual chest vibrocompression, nasotracheal suctioning, and resting
Number of subjects: 20
Study 24473957 — intervention group
Group type: COMPARATOR
Intervention: Control group with 30 minutes of rest
Number of subjects: 20
Study 21168838 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced propofol sedation (BPS)
Number of subjects: 222
Study 21168838 — intervention group
Group type: COMPARATOR
Intervention: Conventional sedation
Number of subjects: 222
Study 18648123 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention rewarding increases in physical activity with TV time (400 counts of PA earns 1 hour of TV)
Number of subjects: 30
Study 18648123 — intervention group
Group type: COMPARATOR
Intervention: Control group (wore activity monitors with free access to TV)
Number of subjects: 30
Study 22230409 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius LS01 (probiotic treatment)
Number of subjects: 38
Study 22230409 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 38
Study 16024583 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at end-tidal concentrations of 2.0% and 3.0%
Number of subjects: 81
Study 16024583 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at end-tidal concentration of 4.0%
Number of subjects: 81
Study 16024583 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of BIS with age
Number of subjects: 81
Study 11888362 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 0
Study 11888362 — intervention group
Group type: COMPARATOR
Intervention: Megestrol
Number of subjects: 0
Study 9405729 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 group (vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Number of subjects: 72
Study 9405729 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT + Vit D3 group (2 mg estradiol valerate + 1 mg cyproterone acetate + vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Number of subjects: 72
Study 9405729 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT group (2 mg estradiol valerate + 1 mg cyproterone acetate)
Number of subjects: 72
Study 9405729 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (calcium lactate 500 mg/day)
Number of subjects: 72
Study 9405729 — intervention group
Group type: COMPARATOR
Intervention: Non-hormone groups (Vit D3 and placebo)
Number of subjects: 72
Study 9405729 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone groups (HRT and HRT + Vit D3)
Number of subjects: 72
Study 7861792 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 0
Study 7861792 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 2471407 — intervention group
Group type: EXPERIMENTAL
Intervention: Office health education program (slide-tape presentation)
Number of subjects: 0
Study 2471407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 29405761 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Light Guided Imagery (HLGI)
Number of subjects: 17
Study 29405761 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (journaling)
Number of subjects: 17
Study 28751158 — intervention group
Group type: EXPERIMENTAL
Intervention: MOMS program (Mentors Offering Maternal Support)
Number of subjects: 246
Study 28751158 — intervention group
Group type: COMPARATOR
Intervention: Normal prenatal care
Number of subjects: 246
Study 26654905 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation (150 μg/d)
Number of subjects: 59
Study 26654905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 24054920 — intervention group
Group type: EXPERIMENTAL
Intervention: LAA occlusion
Number of subjects: 51
Study 24054920 — intervention group
Group type: COMPARATOR
Intervention: No occlusion and oral anticoagulation
Number of subjects: 51
Study 21914595 — intervention group
Group type: EXPERIMENTAL
Intervention: X‐Glove (custom orthotic glove)
Number of subjects: 5
Study 21914595 — intervention group
Group type: COMPARATOR
Intervention: No glove (control condition)
Number of subjects: 5
Study 18992651 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 150
Study 18992651 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (BA)
Number of subjects: 150
Study 16526878 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-LASIK eyes
Number of subjects: 0
Study 16526878 — intervention group
Group type: COMPARATOR
Intervention: Normal healthy eyes
Number of subjects: 0
Study 14522569 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (loading dose 300 mg, followed by 75 mg daily) with pre-treatment of atorvastatin or simvastatin
Number of subjects: 47
Study 14522569 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (loading dose 300 mg, followed by 75 mg daily)
Number of subjects: 47
Study 10998024 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal drops 400 microgram once daily
Number of subjects: 104
Study 10998024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 8641498 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte rates in semen using an immunocytochemical method for differentiation of round cells
Number of subjects: 191
Study 8641498 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of polymorphonuclear (PMN) granulocyte elastase concentration in seminal plasma
Number of subjects: 191
Study 8641498 — intervention group
Group type: EXPERIMENTAL
Intervention: Semen cultures as screening for subclinical infection of the male genital tract
Number of subjects: 191
Study 8641498 — intervention group
Group type: EXPERIMENTAL
Intervention: Determination of local antisperm antibodies (Ab) with the mixed antiglobulin reaction (MAR) immunoglobulin (Ig) G and IgA
Number of subjects: 191
Study 1474533 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 0
Study 1474533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6085376 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (NTP) 5 mg b.i.d. (increased to 20 mg b.i.d. as needed) + Hydrochlorothiazide (HCTZ) 25 mg daily
Number of subjects: 86
Study 6085376 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) b.i.d. + Hydrochlorothiazide (HCTZ) 25 mg daily
Number of subjects: 86
Study 29579168 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg b.i.d.)
Number of subjects: 674
Study 29579168 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA, INR 2-3)
Number of subjects: 674
Study 29579168 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 674
Study 29579168 — intervention group
Group type: COMPARATOR
Intervention: VKA
Number of subjects: 674
Study 29579168 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 674
Study 25666587 — intervention group
Group type: EXPERIMENTAL
Intervention: TheraBite jaw rehabilitation device (TB)
Number of subjects: 0
Study 25666587 — intervention group
Group type: COMPARATOR
Intervention: Speech Language Pathology (SLP) sessions
Number of subjects: 0
Study 25725191 — intervention group
Group type: EXPERIMENTAL
Intervention: Project EX (intervention group)
Number of subjects: 211
Study 25725191 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 211
Study 22964078 — intervention group
Group type: EXPERIMENTAL
Intervention: Bereavement management program
Number of subjects: 402
Study 22964078 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 402
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEIs)
Number of subjects: 26
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARBs)
Number of subjects: 26
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs combined
Number of subjects: 26
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs
Number of subjects: 26
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs in patients receiving amiodarone
Number of subjects: 26
Study 20811347 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs in patients with heart failure
Number of subjects: 26
Study 18387384 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid PSA results (within 15 minutes)
Number of subjects: 188
Study 18387384 — intervention group
Group type: COMPARATOR
Intervention: Delayed PSA results (1 to 4 days by telephone)
Number of subjects: 188
Study 16623818 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 0
Study 16623818 — intervention group
Group type: COMPARATOR
Intervention: Liposomal amphotericin B
Number of subjects: 0
Study 15219340 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking abstinence for 2 weeks
Number of subjects: 60
Study 15219340 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking for 2 weeks
Number of subjects: 60
Study 15219340 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking abstinence and continued smoking
Number of subjects: 60
Study 11695288 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% lignocaine with 1/200,000 adrenaline
Number of subjects: 155
Study 11695288 — intervention group
Group type: COMPARATOR
Intervention: 1.5% mepivacaine
Number of subjects: 155
Study 9203648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG) 200 mg/kg
Number of subjects: 28
Study 9203648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG)
Number of subjects: 28
Study 7862820 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg oxazepam
Number of subjects: 53
Study 7862820 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg oxazepam
Number of subjects: 53
Study 7862820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 3680599 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg sustained release (SR) preparation
Number of subjects: 150
Study 3680599 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg tid dosing regimen
Number of subjects: 150
Study 3680599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 3680599 — intervention group
Group type: EXPERIMENTAL
Intervention: SR PPA 75 mg
Number of subjects: 150
Study 30290638 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 235
Study 30290638 — intervention group
Group type: COMPARATOR
Intervention: Nonanticoagulant
Number of subjects: 235
Study 27542302 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (loading dose 80 mg; biweekly dose 40 mg)
Number of subjects: 229
Study 27542302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 27542302 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 229
Study 26386802 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous enoxaparin
Number of subjects: 910
Study 26386802 — intervention group
Group type: COMPARATOR
Intervention: unfractionated heparin
Number of subjects: 910
Study 23885702 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day stearidonic acid soybean oil
Number of subjects: 0
Study 23885702 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/day EPA oil ethyl ester softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Number of subjects: 0
Study 23885702 — intervention group
Group type: COMPARATOR
Intervention: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Number of subjects: 0
Study 20578930 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg MPH
Number of subjects: 54
Study 20578930 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg MPH
Number of subjects: 54
Study 20578930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 18196427 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard class plus a joint-specific module addressing recovery during the first 12 months for THA patients.
Number of subjects: 320
Study 18196427 — intervention group
Group type: COMPARATOR
Intervention: Standard THA or TKA class addressing recovery immediately after surgery for control patients.
Number of subjects: 320
Study 16263834 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hGH (0.2 U/kg.d)
Number of subjects: 12
Study 14725382 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan
Number of subjects: 104
Study 14725382 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate and 0.3% Triclosan after morning brushing and controlled food intake
Number of subjects: 104
Study 10203935 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine cigarette (.7‐mg estimated nicotine delivery)
Number of subjects: 10
Study 10203935 — intervention group
Group type: COMPARATOR
Intervention: Placebo cigarette (.05‐mg nicotine delivery)
Number of subjects: 10
Study 7726803 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 105
Study 1981363 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated mesalamine
Number of subjects: 0
Study 1981363 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine
Number of subjects: 0
Study 7361347 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoxate
Number of subjects: 300
Study 7361347 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium
Number of subjects: 300
Study 7361347 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline
Number of subjects: 300
Study 7361347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 29453872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatology consultation within 24 hours of hospitalization
Number of subjects: 175
Study 29453872 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (treatment by primary medicine team)
Number of subjects: 175
Study 26917504 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-18 (180 mg, once or twice weekly)
Number of subjects: 21
Study 26917504 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT-18 (360 mg, weekly)
Number of subjects: 21
Study 26917504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 25033590 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program on sun protection
Number of subjects: 3205
Study 23190707 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber dressings with low silver content
Number of subjects: 30
Study 23190707 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber dressings with high silver content
Number of subjects: 30
Study 23190707 — intervention group
Group type: COMPARATOR
Intervention: Antiseptics-free dressings
Number of subjects: 30
Study 20657778 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed methods and triangulation model for data collection
Number of subjects: 725
Study 20657778 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative social science integration
Number of subjects: 725
Study 18410811 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair apposition technique performed by doctors
Number of subjects: 164
Study 18410811 — intervention group
Group type: COMPARATOR
Intervention: Hair apposition technique performed by nurses
Number of subjects: 164
Study 18410811 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes (wound infection, wound healing, bleeding, overall complications)
Number of subjects: 164
Study 16633117 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment group (ATG) with ofloxacin or levofloxacin (single dose or BID for 5 days)
Number of subjects: 139
Study 16633117 — intervention group
Group type: COMPARATOR
Intervention: Supportive treatment only group (STG)
Number of subjects: 139
Study 16633117 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment group (ATG)
Number of subjects: 139
Study 12660335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg/d
Number of subjects: 196
Study 12660335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg/d
Number of subjects: 196
Study 12660335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 240 mg/d
Number of subjects: 196
Study 12660335 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 120 mg twice daily
Number of subjects: 196
Study 10550737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 100 microg
Number of subjects: 22
Study 10550737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 microg
Number of subjects: 22
Study 10550737 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg
Number of subjects: 22
Study 10550737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9051708 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg domperidone
Number of subjects: 14
Study 9051708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2013952 — intervention group
Group type: EXPERIMENTAL
Intervention: Opinion leader education
Number of subjects: 76
Study 2013952 — intervention group
Group type: COMPARATOR
Intervention: Audit and feedback
Number of subjects: 76
Study 2013952 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 7071529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (subcutaneous injection)
Number of subjects: 281
Study 7071529 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccine (subcutaneous injection)
Number of subjects: 281
Study 7071529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (intramuscular injection)
Number of subjects: 281
Study 3908116 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg AG/day
Number of subjects: 170
Study 3908116 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g AG/day
Number of subjects: 170
Study 3908116 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 170
Study 29596644 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound-level intervention (chlorinated drinking water, upgraded sanitation, and handwashing promotion)
Number of subjects: 1799
Study 29596644 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 1799
Study 24963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose S-IFE (1 g/kg/d)
Number of subjects: 136
Study 24963025 — intervention group
Group type: COMPARATOR
Intervention: Control dose S-IFE (approximately 3 g/kg/d)
Number of subjects: 136
Study 24963025 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose S-IFE
Number of subjects: 136
Study 24963025 — intervention group
Group type: COMPARATOR
Intervention: Low-dose S-IFE and Control dose S-IFE
Number of subjects: 136
Study 25631721 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk (Lactobacillus casei Shirota) for 10 days
Number of subjects: 31
Study 25631721 — intervention group
Group type: COMPARATOR
Intervention: Control milk for 10 days
Number of subjects: 31
Study 22551822 — intervention group
Group type: EXPERIMENTAL
Intervention: EPCs and EMPs in patients with arterial ED and MetS
Number of subjects: 50
Study 22551822 — intervention group
Group type: COMPARATOR
Intervention: EPCs and EMPs in patients with MetS but without ED
Number of subjects: 50
Study 22551822 — intervention group
Group type: COMPARATOR
Intervention: EPCs and EMPs in patients without MetS and ED
Number of subjects: 50
Study 19653027 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 5804
Study 19653027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5804
Study 18548958 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure cotton cord
Number of subjects: 340
Study 18548958 — intervention group
Group type: COMPARATOR
Intervention: Cord impregnated with epinephrine
Number of subjects: 340
Study 18548958 — intervention group
Group type: COMPARATOR
Intervention: Chemical retraction (Expa-syl)
Number of subjects: 340
Study 16052544 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-releasing ER formulation
Number of subjects: 52
Study 16052544 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-releasing ER formulation
Number of subjects: 52
Study 16052544 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-releasing ER formulation
Number of subjects: 52
Study 16052544 — intervention group
Group type: EXPERIMENTAL
Intervention: Slightly-fast-releasing ER formulation
Number of subjects: 52
Study 16052544 — intervention group
Group type: EXPERIMENTAL
Intervention: Slightly-slow-releasing ER formulation
Number of subjects: 52
Study 16052544 — intervention group
Group type: COMPARATOR
Intervention: 12-h IV infusion of valproic acid (reference)
Number of subjects: 52